Form 8-K - Current report:
SEC Accession No. 0001789769-24-000070
Filing Date
2024-06-17
Accepted
2024-06-17 17:02:09
Documents
13
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K til-20240613.htm   iXBRL 8-K 37001
  Complete submission text file 0001789769-24-000070.txt   164116

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20240613.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20240613_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20240613_pre.xml EX-101.PRE 13038
16 EXTRACTED XBRL INSTANCE DOCUMENT til-20240613_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 241049119
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)